In a recent corporate action, SBP GROUP (01177) has announced the cancellation of a significant number of its own shares. The company confirmed that on June 4, 2026, it formally extinguished 40.35 million shares that had been previously repurchased.
This move effectively reduces the total number of shares in circulation for the pharmaceutical company. The cancellation of these repurchased shares is a common corporate finance procedure following a buyback program.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments